₹1,140.95-8.05 (-0.70%)
10:53 AM, 12-Dec-2024₹1,140.15-9.25 (-0.80%)
10:44 AM, 12-Dec-2024BSE : 530019
NSE : JUBLPHARMA
Sector : Health care
ISIN Code : INE700A01033
Last Updated: 12-Dec-2024 | 10:53 AM IST
Market Cap (₹ Cr) | 18,175 |
Traded Value (₹ Cr) | 0.18 |
Volume (Shares) | 1,621 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,309.00 |
52-Week High Date | 07-Nov-2024 |
52-Week Low (₹) | 453.60 |
52-Week Low Date | 13-Dec-2023 |
All Time High (₹) | 1,309.00 |
All Time High Date | 07-Nov-2024 |
All Time Low (₹) | 3.05 |
All Time Low Date | 09-May-2001 |
Press Release along with Earnings Presentation for the quarter and half year ended September 30 2024
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 18,163 |
EPS - TTM (₹) [C] | 18.13 |
P/E Ratio (X) [C] | 62.89 |
Face Value (₹) | 1 |
Latest Dividend (%) | 500.00 |
Latest Dividend Date | 02-Aug-2024 |
Dividend Yield (%) | 0.43 |
Book Value Share (₹) [C] | 372.92 |
P/B Ratio (₹) [C] | 3.06 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Quant Small Cap Fund - (G) | 377.58 | 30,59,145 | 1.39 |
Quant Small Cap Fund - (IDCW) | 377.58 | 30,59,145 | 1.39 |
Quant Small Cap Fund - Direct (G) | 377.58 | 30,59,145 | 1.39 |
Quant Small Cap Fund - Direct (IDCW) | 377.58 | 30,59,145 | 1.39 |
Bandhan Small Cap Fund (G) | 61.09 | 4,94,970 | 0.66 |
Bandhan Small Cap Fund (IDCW) | 61.09 | 4,94,970 | 0.66 |
Bandhan Small Cap Fund - Direct (G) | 61.09 | 4,94,970 | 0.66 |
Bandhan Small Cap Fund - Direct (IDCW) | 61.09 | 4,94,970 | 0.66 |
Kotak Special Opportunities Fund - Regular (G) | 55.54 | 4,50,000 | 2.39 |
Kotak Special Opportunities Fund - Regular (IDCW) | 55.54 | 4,50,000 | 2.39 |
Load more
Today's Low/High (₹) | 1,126.70 1,154.00 |
Week Low/High (₹) | 1,118.65 1,234.00 |
Month Low/High (₹) | 1,085.80 1,265.00 |
Year Low/High (₹) | 452.80 1,310.00 |
All time Low/High (₹) | 3.05 1,310.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -5.31% | -5.40% | -0.31 | -0.39% |
1 Month | -4.16% | -4.21% | 3.61 | 3.05% |
3 Month | 8.77% | 8.90% | -1.75 | -3.06% |
6 Month | 54.72% | 54.67% | 6.41 | 5.52% |
1 Year | 146.12% | 146.65% | 17.20 | 17.72% |
3 Year | 89.74% | 89.84% | 38.66 | 40.54% |
Chairman (Non-Executive) : Shyam S Bhartia
Co-Chairman & Non-Exe.Director : Hari S Bhartia
Non-Exec. & Independent Dir. : Vivek Mehra
Non-Exec. & Independent Dir. : SUSHIL KUMAR ROONGTA
Managing Director : Priyavrat Bhartia
Joint Managing Director : Arjun Shanker Bhartia
Non-Exec. & Independent Dir. : Arun Seth
Whole Time Director & CFO : Arvind Chokhany
Company Sec. & Compli. Officer : Naresh Kapoor
Independent Director : Shirish Gundopant Belapure
Whole-time Director : Ramakrishnan Arul
Independent Director : Harsh Mahajan
Independent Director : Shivpriya Nanda
Registered Office: Bhartiagram Gajraula, ,Amroha,Uttar Pradesh-244223 Ph: 91-5924-267200
Email:investors@jubl.com
1. What's the Jubilant Pharmova Ltd share price today?
Jubilant Pharmova Ltd share price was Rs 1,140.95 at 10:53 AM IST on 12th Dec 2024. Jubilant Pharmova Ltd share price was down by 0.70% from the previous closing price of Rs 1,149.00. Jubilant Pharmova Ltd share price trend:
2. How can I quickly analyse the performance of the Jubilant Pharmova Ltd stock?
The performance of the Jubilant Pharmova Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd has a market capitalisation of Rs 18,175 crore.
4. What is Jubilant Pharmova Ltd's 52-week high/low share price?
The Jubilant Pharmova Ltd’s 52-week high share price is Rs 1,309.00 and 52-week low share price is Rs 453.60.
5. Is the Jubilant Pharmova Ltd profitable?
On a consolidated basis, Jubilant Pharmova Ltd reported a profit of Rs 10.50 crore on a total income of Rs 209.50 crore for the quarter ended 2024. For the year ended Sep 2024, Jubilant Pharmova Ltd had posted a profit of Rs 102.50 crore on a total income of Rs 1,774.00 crore.
6. Which are Jubilant Pharmova Ltd’s peers in the Health care sector?
Jubilant Pharmova Ltd’s top 5 peers in the Health care sector are Neuland Labs., ERIS Lifescience, Caplin Point Lab, Jubilant Pharmo, Astrazeneca Phar, Marksans Pharma, Granules India.
7. Who owns how much in Jubilant Pharmova Ltd?
Key changes to the Jubilant Pharmova Ltd shareholding are as follows: